Skip to main content
Figure 3 | BMC Bioinformatics

Figure 3

From: Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response

Figure 3

High CEI1 and CEI3 scores are associated with agent-specific response to neoadjuvant therapy. DNBC patients were given neoadjuvant TFAC (MDA1, MDA/MAQC), FEC (EORTC) or epirubicin only (JBI2). ROC curves indicate the association between (a) high CEI1 or (b) high CEI3 and pathological complete response (pCR) to taxane-based chemotherapy; and (c) high CEI1 or (d) high CEI3 and non-pCR to non-taxane-based chemotherapy.

Back to article page